These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 7608483)

  • 1. Blunted natriuresis and abnormal systemic hemodynamic responses to C-type and brain natriuretic peptides in rats with cirrhosis.
    Komeichi H; Moreau R; Cailmail S; Gaudin C; Lebrec D
    J Hepatol; 1995 Mar; 22(3):319-25. PubMed ID: 7608483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blunted systemic, splanchnic, and renal hemodynamic responses to atrial natriuretic peptide in rats with cirrhosis.
    Ohsuga M; Moreau R; Hartleb M; Komeichi H; Lebrec D
    J Hepatol; 1994 Jan; 20(1):91-6. PubMed ID: 8201228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blunted natriuretic response to low-dose brain natriuretic peptide infusion in nonazotemic cirrhotic patients with ascites and avid sodium retention.
    La Villa G; Riccardi D; Lazzeri C; Casini Raggi V; Dello Sbarba A; Tosti Guerra C; Fronzaroli C; Foschi M; Laffi G; Gentilini P
    Hepatology; 1995 Dec; 22(6):1745-50. PubMed ID: 7489983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative bioactivity of atrial, brain, and C-type natriuretic peptides in conscious sheep.
    Charles CJ; Espiner EA; Richards AM; Nicholls MG; Yandle TG
    Am J Physiol; 1996 Jun; 270(6 Pt 2):R1324-31. PubMed ID: 8764300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of altered systemic hemodynamics in the blunted renal response to atrial natriuretic peptide in rats with cirrhosis and ascites.
    López C; Jiménez W; Arroyo V; La Villa G; Gaya J; Clària J; Rivera F; Rodés J
    J Hepatol; 1989 Sep; 9(2):217-26. PubMed ID: 2530268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of myocardial and renal natriuretic peptides during acute intravascular volume overload in dogs: functional cardiorenal responses to receptor antagonism.
    Borgeson DD; Stevens TL; Heublein DM; Matsuda Y; Burnett JC
    Clin Sci (Lond); 1998 Aug; 95(2):195-202. PubMed ID: 9680502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. C-type natriuretic peptide in chronic renal failure and its action in humans.
    Igaki T; Itoh H; Suga S; Hama N; Ogawa Y; Komatsu Y; Mukoyama M; Sugawara A; Yoshimasa T; Tanaka I; Nakao K
    Kidney Int Suppl; 1996 Jun; 55():S144-7. PubMed ID: 8743538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased plasma levels and blunted effects of brain natriuretic peptide in rats with congestive heart failure.
    Hoffman A; Grossman E; Keiser HR
    Am J Hypertens; 1991 Jul; 4(7 Pt 1):597-601. PubMed ID: 1831369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clearance receptors and endopeptidase: equal role in natriuretic peptide metabolism in heart failure.
    Rademaker MT; Charles CJ; Kosoglou T; Protter AA; Espiner EA; Nicholls MG; Richards AM
    Am J Physiol; 1997 Nov; 273(5):H2372-9. PubMed ID: 9374774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal and vascular effects of C-type and atrial natriuretic peptides in humans.
    Pham I; Sediame S; Maistre G; Roudot-Thoraval F; Chabrier PE; Carayon A; Adnot S
    Am J Physiol; 1997 Oct; 273(4):R1457-64. PubMed ID: 9362312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. C-type natriuretic peptide and brain natriuretic peptide inhibit adenylyl cyclase activity: interaction with ANF-R2/ANP-C receptors.
    Savoie P; de Champlain J; Anand-Srivastava MB
    FEBS Lett; 1995 Aug; 370(1-2):6-10. PubMed ID: 7649305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natriuretic peptide responses to acute and chronic ventricular pacing in sheep.
    Rademaker MT; Charles CJ; Espiner EA; Frampton CM; Nicholls MG; Richards AM
    Am J Physiol; 1996 Feb; 270(2 Pt 2):H594-602. PubMed ID: 8779835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Natriuretic response to the combination of atrial natriuretic peptide and terlipressin in patients with cirrhosis and refractory ascites.
    Gadano A; Moreau R; Vachiery F; Soupison T; Yang S; Cailmail S; Sogni P; Hadengue A; Durand F; Valla D; Lebrec D
    J Hepatol; 1997 Jun; 26(6):1229-34. PubMed ID: 9210608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased plasma levels and effects of brain natriuretic peptide in experimental nephrosis.
    Yokota N; Yamamoto Y; Iemura F; Kita T; Kangawa K; Minamino N; Matsuo H; Eto T
    Nephron; 1993; 65(3):454-9. PubMed ID: 8289999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. C-type natriuretic peptide: a selective cardiovascular peptide.
    Clavell AL; Stingo AJ; Wei CM; Heublein DM; Burnett JC
    Am J Physiol; 1993 Feb; 264(2 Pt 2):R290-5. PubMed ID: 8383462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Haemodynamic responses to a ring-deleted analogue of atrial natriuretic peptide in rats with cirrhosis.
    Moreau R; Tazi KA; Komeichi H; Pussard E; Lebrec D
    Liver; 2000 Feb; 20(1):88-92. PubMed ID: 10726965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atrial natriuretic peptide, brain natriuretic peptide and c-type natriuretic peptide: effects on testicular microcirculation and immunohistochemical localization.
    Collin O; Lissbrant E; Bergh A
    Int J Androl; 1997 Feb; 20(1):55-60. PubMed ID: 9202991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natriuretic and hypotensive effects of brain natriuretic peptide (BNP) in spontaneously hypertensive rats.
    Kita T; Kida O; Kato J; Nakamura S; Eto T; Minamino N; Kangawa K; Matsuo H; Tanaka K
    Life Sci; 1989; 44(21):1541-5. PubMed ID: 2525217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiac natriuretic peptides and pancreatic islet blood flow in anesthetized rats.
    Carlsson PO; Andersson A; Jansson L
    Horm Metab Res; 2001 Mar; 33(3):181-5. PubMed ID: 11355754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of natriuretic peptides on vascular smooth-muscle cells derived from different vascular beds.
    Arjona AA; Hsu CA; Wrenn DS; Hill NS
    Gen Pharmacol; 1997 Mar; 28(3):387-92. PubMed ID: 9068978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.